BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. BRCA1, cell-cell adhesion, Obesity, Leukocyte, Human chorionic gonadotropin, Aspirin)
Bookmark Forward

QuickView for Fpr2 (gene)


Body Atlas

Most Correlated Tissues

  1. Neutrophil of bone marrow
  2. Leukocyte (polymorphonuclear) of peripheral blood
  3. Whole blood
  4. Mononuclear cell of peripheral blood
  5. Myeloid cells of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Sepsis due to Streptococcus agalactiae
  2. Systemic infection
  3. Ebola virus disease
  4. Disorder related to transplantation
  5. Body temperature finding
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. tolfenamic acid
  2. Nitric Oxide
  3. Recombinant Fusion Proteins
  4. CpG ODN 2006
  5. UPF17 peptide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. FGFR1
  2. TRIM6
  3. IPO11
  4. RBM25
  5. TSG101
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 varia…
  2. Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis th…
  3. Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Syst…
  4. FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced alle…
  5. VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Severe Asthma Research Program III-Boston Clinical Site
  2. Body Weight, Aspirin Dose and Pro-resolving Mediators
  3. Aspirin and Neutrophils in Preeclampsia
  4. Genetic Variants and Regulation of Specialized Pro-resolving Mediator
  5. Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.